AINIA is currently working on the definition and assessment of the targeted market for the NEOSUCCESS product and selecting the best tools to successfully achieve our goals in this current European Project. This is being carried out together with BIOTECHPRO and NORVENTO.
Concurrently, lab & pilot experiments are being performed to properly define a robust integrated treatment system and select their operational conditions with the purpose of being implemented after USP set-up to complement it and validate the targeted objectives, especially the recovery and purity of bioSA.
Recent Comments